Andrew Cheng - Jun 3, 2021 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for Andrew Cheng
Stock symbol
ABUS
Transactions as of
Jun 3, 2021
Transactions value $
$0
Form type
4
Date filed
6/7/2021, 04:24 PM
Previous filing
May 18, 2021
Next filing
Jul 6, 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Options Award $0 +22K $0.00 22K Jun 3, 2021 Common Stock 22K $2.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on June 3, 2021, the date of the grant.
F2 The options are fully vested and exercisable as of the date of the grant.